v3.26.1
Goodwill and Other Intangible Assets
6 Months Ended
Jun. 30, 2026
Goodwill and Other Intangible Assets [Abstract]  
Goodwill and Other Intangible Assets

6) Goodwill and Other Intangible Assets

 

    June 30,
2026
    December 31,
2025
 
Goodwill   (see ‘A’ below)   $ 2,946     $ 2,946  
                     
Other intangible assets, net   (see ‘B and C’ below)   $ 54,825     $ 2,808  

 

  A) On June 16, 2025 (the “Closing date”), Healthcare Triangle, Inc. (the “Company”), through its wholly owned subsidiary Quantum Nexus Inc., and Niyama Healthcare, Inc., a Delaware corporation, a provider of Mental Health and Hospital Information Systems technology, across India, Southeast Asia, and Europe (the “Seller”) entered into an Asset and Stock Transfer Agreement (ATA). Pursuant to the ATA, the Company agreed to purchase the Transferred Assets (comprising of contracts, intellectual property and related assets), and (ii) 100% shareholder equity interest in Ezovion Solutions Private Limited, Chennai, India - Hospital Information Systems SaaS Provider (the “Transferred Equity”), as a whole and as a going concern in exchange for the Purchase Price, which comprised the following:

 

(1) $1,494 in cash, (2) $4,601 in equity consideration; and (3) up to $1,200 (having a fair value of nil as of June 30, 2026, and December 31, 2025) in earn-out payments contingent on first-year financial performance targets to be agreed mutually.

 

The transaction resulted in recognition of goodwill with a carrying value of $2,946, as of June 30, 2026, and December 31, 2025. There are no impairment indicators as at June 30, 2026, and December 31, 2025.

 

  B) On January 22, 2026, Healthcare Triangle, Inc. entered into a share purchase agreement to acquire Teyame 360 S.L. (“Teyame”) and Datono Mediacion S.L. (“Datono”) through its wholly owned subsidiary Teyame AI Holdings Inc., effective January 1, 2026. The aggregate purchase price for the Acquired Companies is up to $50,000, subject to the terms and conditions set forth in the Share Purchase Agreement. The consideration consists of a cash payout of $15,000, with the balance settled through issuance of a combination of the Company’s common stock, preferred stock, with an additional earnout component payable in the Company’s preferred stock upon achievement of specified post-closing performance targets.

 

The cash consideration includes: (i) $3,000 paid during 2025 pursuant to an advance agreement dated December 3, 2025, (ii) $6,000 paid during January, 2026 (iii) $3,200 paid during April, 2026, and (iv) $2,800 payable on the earlier of the conditions being met as outlined in the Share Purchase Agreement, or six months from the date of the Share Purchase Agreement (but in no event prior to April 29, 2026).

 

The equity consideration includes (a) restricted shares or pre-funded warrants of the Company’s common stock with an agreed value of $12,000 and (b) a series of the Company’s preferred stock with an agreed value of $18,000 that is convertible into the Company’s common stock, subject to stockholders’ approval. As of June 30, 2026, 55,482 restricted shares of common stock and 424,856 pre-funded warrants convertible to common stock were issued towards the $12,000 common stock issuance, whereas consideration in the form of preferred stocks, convertible to common stock at the Company’s discretion, have been issued subsequent to June 30, 2026 (see Subsequent Events note 17). The number of shares of common stock issued as part of the equity consideration, and the number of shares of common stock underlying the preferred stock, are determined by reference to a “Base Price” equal to the average of the volume-weighted average prices (“VWAPs”) of the Company’s common stock for the five trading days immediately prior to the Closing Date, as further defined in the Share Purchase Agreement. The preferred stock is not convertible into common stock until applicable stockholder approval is obtained as contemplated by the Share Purchase Agreement. The Share Purchase Agreement also includes a mechanism intended to limit issuance in excess of 19.99% of the Company’s outstanding common stock immediately prior to issuance, including the issuance of a pre-funded warrant for any excess shares in lieu of issuing shares in excess of such limitation at closing, and provides that the pre-funded warrant would have a nominal exercise price and be exercisable on a cashless basis, subject to the terms of the Share Purchase Agreement.

 

 

The Share Purchase Agreement also provides for an earnout payable in the Company’s Series C preferred stock to certain key management employees of the Acquired Companies, with an aggregate value of up to $5,000, subject to achievement of specified annual targets as outlined in the Share Purchase Agreement. 

 

Purchase consideration   Amount  
Cash paid   $ 12,200  
Purchase consideration payable     2,800  
Common stock (see also note 17)     12,000  
Preferred stock (convertible into common stock - see also note 17)     18,000  
Earnout consideration     5,000  
Total   $ 50,000  

 

The Company is in the process of determining the fair values of the identifiable assets acquired and liabilities assumed as of the acquisition date in accordance with ASC 805, Business Combinations. As the initial accounting for the business combination is incomplete as of the date of these financial statements, the Company has not yet finalized the purchase price allocation. The provisional amounts recognized reflect management’s best estimates based on information available at this time. The final purchase price allocation, including the determination of fair values of identifiable intangible assets, property and equipment, deferred tax assets and liabilities, and any resulting goodwill, will be completed as soon as practicable and within the measurement period of up to one year from the acquisition date as permitted under ASC 805-10-25-15. Any adjustments to the provisional amounts identified during the measurement period will be recognized in the reporting period in which the adjustment is determined, with a corresponding adjustment to goodwill.

 

C) Other intangible assets

 

          June 30, 2026     December 31, 2025  
    Useful     Gross     Amortization           Net     Gross           Net  
    life     Carrying     expense for     Accumulated     Carrying     Carrying     Accumulated     Carrying  
    (Years)     Amount     the period     Amortization     Amount     Amount     Amortization     Amount  
Intellectual property   3     $ 3,402     $ 605     $ 1,265     $ 2,137     $ 3,402     $ 660     $ 2,742  
Trademark   3       81       13       28       53       81       15       66  
Software   3       449 *     3       434       15       35       35       -  
Technology platform   3 - 4       7,062 *     395       4,574       2,488       -       -       -  
Intangible assets, total         $ 10,994     $ 1,016     $ 6,301     $ 4,693     $ 3,518     $ 710       2,808  

 

During the period ended June 30, 2026, the Company purchased intangible assets amounting to $3. Amortization expense for the quarter ended June 30, 2026 and 2025, were 376 and $0 respectively.

 

* The Company acquired Software and Technology platform as part of the business combination effective January 1, 2026. See note 6(B) for details.